Thalassemia Patients and Friends

Discussion Forums => Iron Chelation Corner => Topic started by: ironjustice on August 13, 2020, 02:44:33 AM

Title: CN128: A New Orally Active Hydroxypyridinone Iron Chelator
Post by: ironjustice on August 13, 2020, 02:44:33 AM

CN128: A New Orally Active Hydroxypyridinone Iron Chelator
Wenteng Chen, Xin Yuan, Zhi Li, Zidong Lu, Sisi Kong, Huidi Jiang, Houbing Du, Xiuhong Pan, Manasi Nandi, Xiaole Kong, Kathryn Brown, Zudong Liu, Guolin Zhang, Robert C. Hider*, and Yongping Yu*
Cite this: J. Med. Chem. 2020, 63, 8, 4215–4226
Publication Date:March 25, 2020
https://doi.org/10.1021/acs.jmedchem.0c00137
Copyright © 2020 American Chemical Society
https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00137

"now in clinical trials for the treatment of β-thalassemia after regular blood transfusion."